Assay interpretation and evidence assessment
Itoh et al. (2021) found changes in chromatin motion and compaction in human cell models exposed to 1,6-hexanediol. Sensitivity to this perturbation must therefore be interpreted with its chromatin effects in mind. This observation is a specificity caution, not evidence that phase separation never occurs.
Molecular fluorescence recovery, component composition and phase coexistence describe different properties. The distinct component behaviour in Feric et al. (2016) and Banani et al. (2016) illustrates why a recovery curve or a single image should be interpreted alongside the other evidence rather than treated as a universal phase diagnosis.
The checked examples support particular demixing, sorting, material-property, assembly and processing findings. They do not establish one mechanism or one function for every nuclear condensate. Body identity, molecular components and biological context remain essential to the interpretation.Evidence and interpretation: Li et al. (2012); Feric et al. (2016); Banani et al. (2016); Sahin et al. (2014); Małszycki et al. (2026); Itoh et al. (2021).
Evidence context and limits
Li et al: Engineered multivalent SH3 and proline-rich-motif proteins and PTB/RNA reconstitution; valency-dependent phase diagrams; droplet/bulk partitioning; dynamic light scattering, SAXS, photobleaching and cryo-EM; additional HeLa puncta and nephrin/Nck/N-WASP reconstitution context. Descriptive primary observations/modelling at the recorded source depth; no operational procedures reproduced. Sol–gel coupling is the authors’ qualified interpretation, not a directly measured universal percolation threshold or nuclear material state. The page preserves likely and confines claims to reconstituted systems.Evidence and interpretation: Li et al. (2012).
Banani et al: Purified engineered polySUMO/polySIM, polySH3/polyPRM, and PTB/polyUCUCU scaffold pairs with fluorescent low-valency clients; phase diagrams, partition coefficients, binding mutants, valency series, and mass-action modeling. Current page claims stay with these engineered systems. Descriptive primary observations/modelling at the recorded source depth; no operational procedures reproduced. SUMO/SIM mutant/GFP controls are not described as controls for every scaffold pair. Does not show all endogenous bodies demix or assign a phase mechanism solely from enrichment.Evidence and interpretation: Banani et al. (2016).
Feric et al: Amplified extrachromosomal nucleoli in X. laevis oocytes, fluorescent subcompartment markers, actin perturbation to permit fusion; purified NPM1/FIB1/rRNA mixtures; FRAP and embedded 50-nm probe microrheology; ATP depletion in oocyte and mammalian-cell conditions. Descriptive primary observations/modelling at the recorded source depth; no operational procedures reproduced. Two protein-rich phases are not a reconstitution of all three nucleolar compartments or a universal nuclear-body model. Aging and ATP observations are component/condition-specific; no standalone FRAP-to-solid-state inference.Evidence and interpretation: Feric et al. (2016).
Sahin et al: Mouse fibroblast and human-cell PML models, with PML/SUMO interaction comparisons. Cell imaging, biochemical assembly comparisons, partner localization and retention. Initial PML assembly and subsequent SUMO/SIM partner retention are distinct cell-model observations, not a whole-body liquid-coexistence measurement.Evidence and interpretation: Sahin et al. (2014).
Itoh et al: Human cell-line chromatin assessed through fluorescent histone markers. This is not a neuronal FUS study. Single-nucleosome motion measurements and chromatin imaging. Chromatin motion/compaction effects in human cell models; no neuronal FUS inference or mechanism diagnosis of every condensate.Evidence and interpretation: Itoh et al. (2021).
Małszycki et al: Human cells with acute SON/SRRM2 loss; precise engineered line details not independently appraised here. Descriptive expression and RNA-splicing comparisons reported in the primary Abstract. Abstract depth; no timing/quantitative effect size/method controls or isolated architectural causality validated.Evidence and interpretation: Małszycki et al. (2026).